News & Insights.
Stay updated with the latest developments from our portfolio companies and insights from the Camellia Venture Capital team.
Follow our investments' milestones, market analysis, and thought leadership in venture capital and emerging technology sectors.
RightCapital Achieves #2 Market Position in Financial Planning Software
Our portfolio company RightCapital has secured the 2nd position in market share for comprehensive financial planning software, surpassing MoneyGuidePro according to the latest Kitces Report. This milestone demonstrates the platform's growing adoption among financial advisors and validates our investment thesis.
ZBeats Receives FDA 510(k) Clearance for ZBPro Diagnostic
ZBeats announced that the ZBPro Diagnostic received FDA 510(k) clearance, enabling broader access to scalable Holter ECG interpretation. This milestone strengthens the company's clinical-grade product roadmap and paves the way for wider clinical deployment.
RightCapital Completes $3.7M Series A Round to Accelerate Innovation
In December 2018, RightCapital closed a $3.7 million Series A round led by Camellia Venture Capital to fuel product enhancements, integrations, and greater growth across advisor workflows.